Literature DB >> 32047294

Drug resistance and tolerance in fungi.

Judith Berman1, Damian J Krysan2.   

Abstract

Systemic fungal infections pose a serious clinical problem. Treatment options are limited, and antifungal drug resistance is increasing. In addition, a substantial proportion of patients do not respond to therapy despite being infected with fungi that are susceptible to the drug. The discordance between overall treatment outcome and low levels of clinical resistance may be attributable to antifungal drug tolerance. In this Review, we define and distinguish resistance and tolerance and discuss the current understanding of the molecular, genetic and physiological mechanisms that contribute to those phenomena. Distinguishing tolerance from resistance might provide important insights into the reasons for treatment failure in some settings.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32047294      PMCID: PMC7231573          DOI: 10.1038/s41579-019-0322-2

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  121 in total

Review 1.  The global problem of antifungal resistance: prevalence, mechanisms, and management.

Authors:  David S Perlin; Riina Rautemaa-Richardson; Ana Alastruey-Izquierdo
Journal:  Lancet Infect Dis       Date:  2017-07-31       Impact factor: 25.071

2.  The unmet clinical need of novel antifungal drugs.

Authors:  Damian J Krysan
Journal:  Virulence       Date:  2017-02-17       Impact factor: 5.882

Review 3.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

Review 4.  Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.

Authors:  Maiken Cavling Arendrup; Thomas F Patterson
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

5.  The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

Authors:  David R Andes; Nasia Safdar; John W Baddley; Barbara Alexander; Lisa Brumble; Allison Freifeld; Susan Hadley; Loreen Herwaldt; Carol Kauffman; G Marshall Lyon; Vicki Morrison; Thomas Patterson; Trish Perl; Randall Walker; Tim Hess; Tom Chiller; Peter G Pappas
Journal:  Transpl Infect Dis       Date:  2016-11-14       Impact factor: 2.228

Review 6.  Nosocomial fungal infections: epidemiology, infection control, and prevention.

Authors:  George J Alangaden
Journal:  Infect Dis Clin North Am       Date:  2011-03       Impact factor: 5.982

Review 7.  Antifungal pharmacokinetics and pharmacodynamics.

Authors:  Alexander J Lepak; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

8.  Important new therapies for methicillin-resistant Staphylococcus aureus.

Authors:  Matteo Bassetti; Alessia Carnelutti; Nadia Castaldo; Maddalena Peghin
Journal:  Expert Opin Pharmacother       Date:  2019-10-17       Impact factor: 3.889

9.  Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia.

Authors:  Alexander Rosenberg; Iuliana V Ene; Maayan Bibi; Shiri Zakin; Ella Shtifman Segal; Naomi Ziv; Alon M Dahan; Arnaldo Lopes Colombo; Richard J Bennett; Judith Berman
Journal:  Nat Commun       Date:  2018-06-25       Impact factor: 14.919

10.  Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

Authors:  Michael A Pfaller; Daniel J Diekema; John D Turnidge; Mariana Castanheira; Ronald N Jones
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

View more
  95 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp.

Authors:  Jana Tits; Freya Cools; Kaat De Cremer; Katrijn De Brucker; Judith Berman; Kristof Verbruggen; Bert Gevaert; Paul Cos; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance.

Authors:  Caitlin H Kowalski; Kaesi A Morelli; Daniel Schultz; Carey D Nadell; Robert A Cramer
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-26       Impact factor: 11.205

4.  Ultra-fast proteomics with Scanning SWATH.

Authors:  Christoph B Messner; Vadim Demichev; Nic Bloomfield; Jason S L Yu; Matthew White; Marco Kreidl; Anna-Sophia Egger; Anja Freiwald; Gordana Ivosev; Fras Wasim; Aleksej Zelezniak; Linda Jürgens; Norbert Suttorp; Leif Erik Sander; Florian Kurth; Kathryn S Lilley; Michael Mülleder; Stephen Tate; Markus Ralser
Journal:  Nat Biotechnol       Date:  2021-03-25       Impact factor: 54.908

Review 5.  Mechanisms of Candida Resistance to Antimycotics and Promising Ways to Overcome It: The Role of Probiotics.

Authors:  Konstantin A Demin; Aleksandr G Refeld; Anna A Bogdanova; Evgenya V Prazdnova; Igor V Popov; Olga Yu Kutsevalova; Alexey M Ermakov; Anzhelica B Bren; Dmitry V Rudoy; Vladimir A Chistyakov; Richard Weeks; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-18       Impact factor: 4.609

Review 6.  Plasmonic nano-antimicrobials: properties, mechanisms and applications in microbe inactivation and sensing.

Authors:  Xingda An; Shyamsunder Erramilli; Björn M Reinhard
Journal:  Nanoscale       Date:  2021-02-04       Impact factor: 7.790

Review 7.  Programmed Cell Death: Central Player in Fungal Infections.

Authors:  Giorgio Camilli; Mariana Blagojevic; Julian R Naglik; Jonathan P Richardson
Journal:  Trends Cell Biol       Date:  2020-12-05       Impact factor: 20.808

Review 8.  Candida albicans biofilms and polymicrobial interactions.

Authors:  Nicole O Ponde; Léa Lortal; Gordon Ramage; Julian R Naglik; Jonathan P Richardson
Journal:  Crit Rev Microbiol       Date:  2021-01-22       Impact factor: 7.624

9.  Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells.

Authors:  Rossana de Aguiar Cordeiro; Ana Luiza Ribeiro Aguiar; Bruno Nascimento da Silva; Lívia Maria Galdino Pereira; Fernando Victor Monteiro Portela; Zoilo Pires de Camargo; Reginaldo Gonçalves de Lima-Neto; Débora de Souza Collares Maia Castelo-Branco; Marcos Fábio Gadelha Rocha; José Júlio Costa Sidrim
Journal:  Front Cell Infect Microbiol       Date:  2021-04-22       Impact factor: 5.293

10.  Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Candida spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability.

Authors:  A Espinel-Ingroff; M Sasso; J Turnidge; M Arendrup; F Botterel; N Bourgeois; B Bouteille; E Canton; S Cassaing; E Dannaoui; M Dehais; L Delhaes; D Dupont; A Fekkar; J Fuller; G Garcia-Effron; J Garcia; G M Gonzalez; N P Govender; H Guegan; J Guinea; S Houzé; C Lass-Flörl; T Pelaez; A Forastiero; M Lackner; R Magobo
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.